In hindsight, if we end up partnering and diluting via trading out WI, especially with our “hero and saviour” suppressing the share price and hence significantly affecting that level of dilution, sole risking and funding hasn’t given us much bang for buck.
- Forums
- ASX - By Stock
- IVZ
- Ann: Quarterly Report and Cashflow
Ann: Quarterly Report and Cashflow, page-26
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVZ (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
0.002(2.94%) |
Mkt cap ! $99.25M |
Open | High | Low | Value | Volume |
6.9¢ | 7.0¢ | 6.7¢ | $101.9K | 1.487M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 354854 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 37842 | 0.070 |
1 | 100000 | 0.069 |
5 | 240973 | 0.068 |
5 | 887635 | 0.067 |
5 | 226496 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 354854 | 3 |
0.071 | 5417 | 1 |
0.073 | 325000 | 2 |
0.074 | 200000 | 2 |
0.075 | 737400 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online